Susquehanna International Group
SMMT icon

Susquehanna International Group’s Summit Therapeutics SMMT Stock Holding History

Susquehanna International Group’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.5M Sell
1,239,300
-563,400
-31% -$9.11M ﹤0.01% 2026
2025
Q4 		$31.5M Buy
1,802,700
+411,000
+30% +$7.73M ﹤0.01% 1771
2025
Q3 		$28.8M Buy
1,391,700
+345,400
+33% +$8.38M ﹤0.01% 1838
2025
Q2 		$22.3M Buy
1,046,300
+296,200
+39% +$6.75M ﹤0.01% 1898
2025
Q1 		$14.5M Buy
750,100
+443,300
+144% +$8.89M ﹤0.01% 2080
2024
Q4 		$5.48M Sell
306,800
-304,300
-50% -$5.9M ﹤0.01% 3455
2024
Q3 		$13.4M Buy
611,100
+475,000
+349% +$6.64M ﹤0.01% 2249
2024
Q2 		$1.06M Buy
136,100
+114,800
+539% +$620K ﹤0.01% 6432
2024
Q1 		$88.2K Buy
+21,300
New +$84.7K ﹤0.01% 11287
2023
Q4 		– Sell
-13,300
Closed -$24.9K – 13230
2023
Q3 		$24.9K Sell
13,300
-1,000
-7% -$1.91K ﹤0.01% 11542
2023
Q2 		$35.9K Sell
14,300
-210,100
-94% -$383K ﹤0.01% 11460
2023
Q1 		$393K Sell
224,400
-457,400
-67% -$1.25M ﹤0.01% 9138
2022
Q4 		$2.9M Buy
+681,800
New +$1.24M ﹤0.01% 4072

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's SMMT Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Summit Therapeutics (SMMT) in Q1 2026: 603,933 shares worth $11.5M. The stake represents ﹤0.01% of the portfolio and ranks #2909 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in SMMT as recently as Q3 2025.

Susquehanna International Group first reported a position in SMMT in Q3 2017 and has held it in 22 quarters since. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Susquehanna International Group held 603,933 shares of Summit Therapeutics worth $11.5M as of Q1 2026.
  • Summit Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Summit Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2909 holding.
  • Susquehanna International Group first reported a position in Summit Therapeutics in Q3 2017 and has held it in 22 quarters since.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.